Barcelona-based Sycai Medical has closed a €3M funding round backed by LUMO Labs, Ship2B Ventures, Athos Capital, and Namarel Ventures.

Researchers in Spain are working to develop faster, more accurate methods for detecting viruses like human norovirus and hepatitis A in fresh produce. The ...

Football legends Michael Vick and Michael Strahan are set to enter the College Football Hall of Fame.

Caffeine isn’t the only good thing about drinking coffee on the regular. "Coffee is also a unique source of soluble fiber ," ...

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Special Report' as President-elect Donald ...

Broadvoice, a leading global customer experience technology provider, announced today the launch of its 2025 CX World Tour, designed to introduce partners, distributors and end-users to its new Global ...

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize ... at 18:00 MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function Transdermal GFR ...

The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the ...

Quezon City.  Despite the global ban, the EcoWaste Coalition continues to uncover the illegal use of mercury in unauthorized ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in around one hour.

Throughout last year, Qiagen was granted FDA clearance for four QIAstat-Dx ... QIAstat-Dx system operations in Esplugues de Llobregat, Barcelona, Spain. Due to open early next year, the new ...